ROCHESTER, Minn.--(BUSINESS WIRE)--Nucleus RadioPharma, the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, today announced the expansion of its executive leadership team with Mark Przekop joining as Chief Operating Officer. As a veteran with over 35 years in the nuclear pharmacy and radiopharmaceuticals industry, Mark brings extensive commercial and operational experience in expanding supply chain networks, marketing and regulatory compliance oversight..

明尼苏达州罗切斯特市（商业新闻短讯）--世界上第一家完全集成放射性药物开发、制造和供应链组织Nucleus RadioPharma今天宣布扩大其执行领导团队，Mark Przekop加入为首席运营官。作为一名在核制药和放射性制药行业拥有35年以上经验的资深人士，Mark在扩展供应链网络、营销和法规遵从性监督方面拥有丰富的商业和运营经验。。

“Mark’s experience and wealth of knowledge in business strategy, commercial manufacturing, and supply chain oversight in radiopharmaceuticals, as demonstrated by his impressive background in nuclear medicine is a perfect fit for us,” said Charles S. Conroy, CEO of Nucleus RadioPharma. “Over the past year, we’ve reached major milestones, including closing our recent oversubscribed $56 million Series A to greatly increase the accessibility of radiopharmaceuticals to cancer patients, and we look forward to leveraging Mark’s expertise in business strategy to continue bringing life-saving treatments to patients with cancer.”.

Nucleus RadioPharma首席执行官查尔斯·康罗伊（Charles s.Conroy）表示：“马克在放射性药物的商业战略、商业制造和供应链监督方面的经验和丰富知识，正如他在核医学方面令人印象深刻的背景所证明的那样，非常适合我们。”。“在过去的一年中，我们已经达到了重要的里程碑，包括结束了我们最近超额认购的5600万美元的A系列，以大大提高癌症患者对放射性药物的可及性，我们期待着利用Mark在商业战略方面的专业知识，继续为癌症患者提供挽救生命的治疗。”。

Prior to joining Nucleus, Mark held multiple roles at ARTMS, Inc., most recently as Chief Operating Officer responsible for overseeing supply chains for business operations, product development and chemistry teams, managing regulatory strategy for the ARTMS portfolio, and cultivating business partnerships with key U.S.

在加入Nucleus之前，Mark曾在ARTMS，Inc.担任多个职位，最近担任首席运营官，负责监督商业运营、产品开发和化学团队的供应链，管理ARTMS组合的监管策略，并与美国主要。

nuclear pharmacy customers. He was also Vice President of Pharmacy Services at Jubilant Radiopharma, providing executive sales and operational support over the entire East Region, which included 26 radiopharmacies and PET manufacturing..

核药房客户。他还是喜庆放射制药公司（Jubilant Radiopharma）药房服务副总裁，为整个东部地区（包括26家放射药店和宠物制造业）提供高管销售和运营支持。。

Please visit https://nucleusrad.com/#about for more information and to learn more about Nucleus RadioPharma’s partnering opportunities.

请访问https://nucleusrad.com/#about了解更多信息并了解Nucleus RadioPharma的合作机会。

About Nucleus RadioPharma

关于Nucleus RadioPharma

Nucleus RadioPharma is a Contract Development and Manufacturing Organization (CDMO) dedicated to building robust and reliable clinical and commercial supply chains for targeted radiotherapies. Nucleus RadioPharma's mission is to ensure cancer patients can access potentially lifesaving radiopharmaceuticals by developing technologies to modernize the clinical development, manufacturing, and supply chain of these promising new treatment tools..

Nucleus RadioPharma是一家合同开发和制造组织（CDMO），致力于为靶向放射治疗建立强大可靠的临床和商业供应链。Nucleus RadioPharma的使命是通过开发技术，使这些有前途的新治疗工具的临床开发，制造和供应链现代化，确保癌症患者能够获得潜在的挽救生命的放射性药物。。